Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Influenza virus vaccine live intranasal (trivalent) - MedImmune

Drug Profile

Influenza virus vaccine live intranasal (trivalent) - MedImmune

Alternative Names: CAIV-T; Fluenz; FluMist; Influenza vaccine live intranasal; Trivalent live attenuated seasonal influenza vaccine - MedImmune

Latest Information Update: 02 Jul 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator University of Michigan
  • Developer AstraZeneca; MedImmune
  • Class Influenza virus vaccines live; Viruses
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Influenza virus infections

Most Recent Events

  • 02 Jul 2019 Influenza virus vaccine live intranasal is not yet available for Influenza virus infections (Prevention) in Liechtenstein, Iceland (Intranasal)
  • 30 Jun 2016 Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) recommends against the use of FluMist®
  • 01 Feb 2012 Launched for Influenza virus infections in United Kingdom (Intranasal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top